Login / Signup
SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action.
Milton Packer
Published in:
Diabetes care (2020)
Keyphrases
</>
blood glucose
insulin resistance
metabolic syndrome
type diabetes
adipose tissue